Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, and Cancer Immunotherapy and Biomarkers.
Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity
Pathway Commons 2019 Update: integration, analysis and exploration of pathway data
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis
A Landscape of Metabolic Variation across Tumor Types
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade
Perturbation biology nominates upstream–downstream drug combinations in RAF inhibitor resistant melanoma cells
Protein Domain Hotspots Reveal Functional Mutations across Genes in Cancer
Genome-wide inference of natural selection on human transcription factor binding sites